Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

NRAS A146

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

EGFR exon 19 deletion + NRAS Q61K (3)

PD-L1 expression + NRAS Q61R + BRAF D594N (2)

CDKN2A Negative + NRAS Mutation (1)

Chr t(11;14) + NRAS mutation (1)

KRAS wild-type + NRAS wild-type + MSI-H/dMMR (1)

MLL-AFF1 fusion + NRAS mutation (1)

NRAS mutation + BRAF wild-type (1)

NRAS wild-type + NOTCH4 mutation (1)

EGFR exon 19 deletion + NRAS Q61K (3)

PD-L1 expression + NRAS Q61R + BRAF D594N (2)

CDKN2A Negative + NRAS Mutation (1)

Chr t(11;14) + NRAS mutation (1)

KRAS wild-type + NRAS wild-type + MSI-H/dMMR (1)

MLL-AFF1 fusion + NRAS mutation (1)

NRAS mutation + BRAF wild-type (1)

NRAS wild-type + NOTCH4 mutation (1)

›

NRAS A146	Colorectal Cancer	NRAS A146	Colorectal Cancer	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1
NRAS A146	Colorectal Cancer	NRAS A146	Colorectal Cancer	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1